BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 14723115)

  • 1. Perspectives. What the drug benefit looks like now.
    Med Health; 2003 Nov; 57(43):1, 7-8. PubMed ID: 14723115
    [No Abstract]   [Full Text] [Related]  

  • 2. Congressional healthcare outlook: prescription drugs.
    Graham SB
    Hosp Outlook; 2001 Jul; 4(5):6, 12. PubMed ID: 11478182
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare and the politics of prescription drug pricing.
    Oberlander J
    N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs, debates, deals, and deficits.
    Scott JS
    Healthc Financ Manage; 2002 Dec; 56(12):30, 33. PubMed ID: 12516156
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare agreement: premium support demo ... maybe.
    Med Health; 2003 Nov; 57(43):1-2. PubMed ID: 14723114
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare at the crossroads: a roundtable discussion on prescription drug coverage.
    Bandow D; Cahill J; Carey MA; Neuman P; Allison-Ottey S; Perkins RW; Rother J
    Mod Healthc; 2003 Nov; 33(45):suppl 8 p. following 16. PubMed ID: 14666551
    [No Abstract]   [Full Text] [Related]  

  • 7. In Beltway, all eyes are on drug benefit.
    Gardner J
    Mod Healthc; 2000 May; 30(21):44. PubMed ID: 11067548
    [No Abstract]   [Full Text] [Related]  

  • 8. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Emmer S; Allendorf L
    J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinton proposal begins debate on Medicare prescription benefit.
    Weiss HP
    Balance; 1999; 3(5):6-7. PubMed ID: 10662381
    [No Abstract]   [Full Text] [Related]  

  • 10. Advocating for a Medicare prescription drug benefit.
    Rother J
    Yale J Health Policy Law Ethics; 2003; 3(2):279-90. PubMed ID: 14577144
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug card setback highlights need for cost relief.
    Gundling RL
    Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare Part D--the product of a broken process.
    Slaughter LM
    N Engl J Med; 2006 Jun; 354(22):2314-5. PubMed ID: 16738267
    [No Abstract]   [Full Text] [Related]  

  • 13. Access to Medicare Part D gap coverage more scarce in 2007.
    Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
    [No Abstract]   [Full Text] [Related]  

  • 14. The other drug war. Administration, HMOs playing hardball over prescription medicine benefit.
    Hallam K
    Mod Healthc; 1999 Oct; 29(40):44. PubMed ID: 10621454
    [No Abstract]   [Full Text] [Related]  

  • 15. Can we afford all this?
    Dickerson JF
    Time; 2003 Dec; 162(23):48-51. PubMed ID: 14712554
    [No Abstract]   [Full Text] [Related]  

  • 16. An introduction to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Siegel S
    Health Care Law Mon; 2004 Jan; ():3-14. PubMed ID: 14750394
    [No Abstract]   [Full Text] [Related]  

  • 17. The challenge of expanding health benefits for the aged.
    Elwood TW
    J Allied Health; 2000; 29(4):189-95. PubMed ID: 11147184
    [No Abstract]   [Full Text] [Related]  

  • 18. More than the drug benefit.
    Olsen GG
    Rehab Manag; 2004 Apr; 17(3):42-4. PubMed ID: 15067925
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicare prescription drug/reform act: medicine chest or Pandora's box?
    Hager MH
    J Am Diet Assoc; 2004 Jun; 104(6):890-1. PubMed ID: 15175585
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
    Fise T
    Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.